Contact this trialFirst, we need to learn more about you.
MQ710 + Pembrolizumab for Solid Tumor Cancers
Recruiting1 awardPhase 1
Commack, New York
This trial looks at the effects of a new drug, MQ710, on people with advanced or relapsed solid tumor cancers. It will find the best dose with fewest side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service